Trials / Completed
CompletedNCT05829798
An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Aptissen SA · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre, independent assessment study on SYNOLIS VA 80/160 and SYNOLIS VA 40/80 over a period of 24 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SYNOLIS VA 80/160 | Single 4mL intra-articular injection of SYNOLIS VA 80/160 |
| DEVICE | SYNOLIS VA 40/80 | Single 2mL intra-articular injection of SYNOLIS VA 40/80 |
Timeline
- Start date
- 2021-01-14
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2023-04-26
- Last updated
- 2023-04-26
Locations
3 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT05829798. Inclusion in this directory is not an endorsement.